Evidence map›Paper›PMID 32751972›Full record

ReviewViruses2020

Cell Cycle Regulation in Macrophages and Susceptibility to HIV-1.

Isabella A T M Ferreira, J Zachary Porterfield, Ravindra K Gupta, Petra Mlcochova

Open access · goldAbstract readReview
In one paragraph

Review in Viruses, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 29 citations in OpenAlex.

  1. Manipulation of the cell cycle by HIV-1.Biochemical Society transactions · 2026
    Review
  2. Review
  3. Review
  4. Immunomodulatory Effects ofAntioxidants (Basel, Switzerland) · 2025
    Article
  5. Article
  6. Article
  7. Review
  8. Macrophage Cell Cycle.Results and problems in cell differentiation · 2024
    Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 3 countries.

Isabella A T M FerreiraCambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge CB20AW, UK.
J Zachary PorterfieldDepartment of Microbiology, University of Kentucky, Lexington, KY 40536, USA.
Ravindra K GuptaCambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge CB20AW, UK.
Petra MlcochovaCambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge CB20AW, UK.ORCID 0000-0001-6908-9363
University of Cambridge · GBUniversity of Kentucky · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Macrophages are the first line of defence against invading pathogens. They play a crucial role in immunity but also in regeneration and homeostasis. Their remarkable plasticity in their phenotypes and function provides them with the ability to quickly respond to environmental changes and infection. Recent work shows that macrophages undergo cell cycle transition from a G0/terminally differentiated state to a G1 state. This G0-to-G1 transition presents a window of opportunity for HIV-1 infection. Macrophages are an important target for HIV-1 but express high levels of the deoxynucleotide-triphosphate hydrolase SAMHD1, which restricts viral DNA synthesis by decreasing levels of dNTPs. While the G0 state is non-permissive to HIV-1 infection, a G1 state is very permissive to HIV-1 infection. This is because macrophages in a G1 state switch off the antiviral restriction factor SAMHD1 by phosphorylation, thereby allowing productive HIV-1 infection. Here, we explore the macrophage cell cycle and the interplay between its regulation and permissivity to HIV-1 infection.

Indexed as

Cell CycleAnimalsCell Cycle CheckpointsCells, CulturedDNA DamageG1 PhaseGram-Negative BacteriaHistone Deacetylase InhibitorsHIV-1HumansMacrophagesPhosphorylationResting Phase, Cell CycleSAM Domain and HD Domain-Containing Protein 1vif Gene Products, Human Immunodeficiency Virusvpr Gene Products, Human Immunodeficiency VirusHistone Deacetylase InhibitorsSAM Domain and HD Domain-Containing Protein 1vif Gene Products, Human Immunodeficiency Virusvif protein, Human immunodeficiency virus 1vpr Gene Products, Human Immunodeficiency Virusvpr protein, Human immunodeficiency virus 1cell arrestcell cycleG0/G1 phaseHIVmacrophageSAMHD1

Identifiers

PMID32751972
PMCPMC7472357
OpenAlexW3046621284

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.